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Objective. Retinoblastoma-associated protein 48 (RbAp48) has been recently discovered as a radiosensitive
gene. We aimed to investigate the role of RbAp48 in radiosensitivity of cervical cancer cells in vivo and in vitro.
Methods.We used real-time RT-PCR and Western blot assay to examine the expression of RbAp48 in irradi-
ated cervical cancer cell lines, including SiHa, Caski, and HeLa cells. The role of RbAp48 in radiosensitivity of
cervical cancer cells was assessed by cell proliferation, counting, survival, and apoptosis as well as cell cycle
and tumor growth assays with RbAp48 overexpression or gene silencing.
Results. The expression of RbAp48 was increased in irradiated cervical cancer cell lines. Overexpression of
RbAp48 induced G2/M arrest and apoptosis in irradiated cells, which was related to upregulation of p53, Rb
and caspase-8 expression. Adenovirus-RbAp48 infection and irradiation synergistically inhibited tumor growth
in nude mice.
Conclusions. RbAp48 is a radiation-inducible gene in cervical cancer cells because of enhanced radiosensitivity
of cervical cancer cells in vivo and in vitro. RbAp48 may be a potential target to improve the results of radiation
therapy for patients with cervical cancer.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Cervical cancer is one of the major causes of death and illness in
women globally [1,2]. Radical hysterectomy is the principal treatment;
the therapeutic efﬁcacy of radiation is limited by radiation resistancerobiology, ShandongUniversity
g 250012, China. Fax: +86 531
gzhao@yahoo.cn (W. Zhao).
work.
nc. Open access under CC BY-NC-ND license[3]. Identifying novel molecules involved in radiation sensitivity of
cervical cancer cells can provide promising prospects for the advance-
ment of radiation therapy.
RbAp48, a 48-kDa protein, initially identiﬁed as a retinoblastoma-
binding protein [4], plays an important role in nucleosome assembly
and histone modiﬁcation [5–9]. RbAp48 is a member of the nucleosome
remodeling histone deacetylase (HDAC) complex [10], the Sin3 complex
[11], and the CAF-1 complex [12]. E2F-1 and RbAp48 are physically asso-
ciated in the presence of Rb and HDAC [13], so RbAp48 is involved in
transcriptional regulation of E2F-responsive genes. In addition, RbAp48
is a positive regulator of K-Ras but a negative regulator of H-Ras and
N-Ras. Constitutive activation of K-Ras induces radiation sensitivity,
and H-Ras contributes to increased radiation resistance [14]. Moreover,
RbAp48 has been predicted as a radiosensitive gene; overexpression of
RbAp48 induced radiosensitization in breast cancer and melanoma cell.
602 L. Zheng et al. / Gynecologic Oncology 130 (2013) 601–608lines [15]. However, the role of RbAp48 in radiation sensitivity of cervical
cancer cells is still unknown.
Our previous studies demonstrated that RbAp48 is a critical media-
tor that controls HPV16 transforming activity in HPV-induced cervical
carcinogenesis [16]. In the present study, we investigated the associa-
tion of RbAp48 and radiosensitivity of cervical cancer cells and the
expression of related genes, p53 and Rb, which play important roles in
cellular response of radiation. Both in vitro and in vivo studies demon-
strated that RbAp48 may increase the radiation sensitivity of cervical
cancer cells.
Materials and methods
Cell culture and ionizing radiation treatment
The cervical cancer cell lines SiHa, Caski and HeLa obtained
from the American Type Culture Collection (Manassas, VA) were
cultured in DMEM (Invitrogen, Carlsbad, CA) containing 10% fetal
calf serum (Invitrogen), 100 IU/ml penicillin, 100 μg/ml streptomycin
(Sigma-Aldrich, St. Louis, MO, USA), and 2 mmol/l L-glutamine.
Cells were exposed to X-ray irradiation at a single dose of 0, 2, 4
or 6 Gy at 300 cGy/min by the use of the Siemens Primus accelerator
with 6 MV-photons at room temperature. Then cells were returned to
the incubator and incubated at 37 °C, 5% CO2.
Transfection and establishment of RbAp48-overexpressed stable lines
SiHa, Caski and HeLa cells were seeded into 6-well culture plates
at 1 × 105 cells/well and cultured in medium without antibiotics.Fig. 1. Irradiation increases the expression of RbAp48 in cervical cancer cell lines. (A) Real
doses of radiation. Expression of RbAp48 in each sample was normalized to that of β-actin
set to 1. Data are mean ± SD from 3 independent experiments. **, P b 0.01; ***, P b 0.001
Caski and HeLa cells treated with radiation. β-Tubulin was a loading control. (C) The RbApSmall interfering RNA (siRNA) oligonucleotides (Sigma-Aldrich),
pcDNA3.1-RbAp48 or pcDNA3.1 were transfected into cells by the
Lipofectamine 2000 reagent method (Invitrogen). Cells were harvested
and used for further experiments 48 h after transfection. The sequences
of double-stranded siRNA oligonucleotides are in Supplemental Table 1.
For generating RbAp48-overexpressed stable lines, pcDNA3.1-RbAp48-
or pcDNA3.1-transfected cell lines were created as described [16].Adenovirus infection
Adenovirus 5 (Ad5)-RbAp48 vector, an E1, E3-deleted replication-
deﬁcient vector that expresses RbAp48 under the control of a cyto-
megalovirus promoter was obtained from Vector Gene Technology
(China). Cells were plated in 6-well plates at 2 × 105 cells/well and
incubated until approximately 70–90% conﬂuence; the culturemedium
was aspirated, then cells were washed with prewarmed phosphate-
buffed saline (PBS) and incubated with Ad5-enhanced green ﬂuorescent
protein (Ad5-EGFP) or Ad5-RbAp48 at multiplicity of infection (MOI)
of 50 plaque forming units (pfu) at 37 °C.Western blot assay
Total protein was extracted from cells as described by the use of
NP-40 lysis buffer (Beyotime, China).Western blot assaywasperformed
as described [16] with the primary antibody against RbAp48 (1:1000,
Abcam, UK). β-Tubulin monoclonal antibody was a control (1:2000,
Sigma-Aldrich).-time RT-PCR assay of RbAp48 mRNA levels in SiHa, Caski and HeLa cells treated with
. The normalized values were then calibrated against untreated cell values arbitrarily
versus the no treated cells. (B) Western blot assay of RbAp48 protein levels in SiHa,
48/tubulin ratio for each was analyzed by densitometry and shown as bar graphs.
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Cell proliferation assay involved the use of Cell Counting Kit 8
(Dojindo, Japan) following the manufacturer's recommendation or cell
counting assay as described [16]. For survival and soft agar colony-
formation assay, cells were treated as above and detected as described
[15,17].Flow cytometry
Cells transfected with plasmid or siRNA were plated in 100-mm
dishes, then exposed to 0 or 6 Gy irradiation. After 24 h of incuba-
tion, cells were washed twice with PBS and collected in tubes atFig. 2. Knockdown of RbAp48 reduces radiosensitivity of cervical cancer cells. (A) Western b
(si-RbAp48-1, -2) or control siRNA (si-control). β-Tubulin was a loading control. Assay fo
(E) of RbAp48-knockdown (si-RbAp48) and control cervical cancer cells (si-control) treated w
**, P b 0.01; ***, P b 0.001 versus the si-control group.1 × 106 cells/tube. For cell cycle analysis, cells were ﬁxed and stained
as described [15]. For apoptosis analysis, cells were collected and
stained by the use of a cell apoptosis kit (BestBio, China). Cells were
then assayed by ﬂow cytometry (Beckman Coulter, Germany).Quantitative real-time RT-PCR
Total RNA was isolated by the use of a Trizol reagent (Invitrogen) as
described [18]. Then 5 μg total RNAwas reverse transcribed to cDNA by
the use of the real-time PCR Kit AMV (TaKaRa Bio, Tokyo). Quantitative
real-time PCR of mRNA levels of p53, Rb and caspase-8 was performed
as described [16]. The primers for real time RT-PCR are in Supplemental
Table 2.lot assay of RbAp48 protein level in cervical cancer cells transfected with RbAp48 siRNA
r cell proliferation (B), cell counting (C), survival (D) and soft agar colony formation
ith doses of radiation. Data are mean ± SD from 3 independent experiments. *, P b 0.05;
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We purchased 6-week-old female BALB/c nude mice (nu/nu) from
Beijing Vital River Laboratories (VRL) and mice were quarantined for
2 weeks. All experiments were conducted in accordance with the
guidelines of the institutional Animal Care and Use Committee and
the protocol was approved by the ethical committee of the Shandong
University School of Medicine. The xenograft mouse model involved
injecting SiHa or HeLa cells (1 × 107 per mouse in 100 μl PBS)
into the right leg of mice. Two weeks later, when tumor xenografts
were established, mice were randomly assigned to 5 groups (8 mice
per group) for treatment: (1) control (PBS); (2) Ad5-EGFP alone;
(3) Ad5-EGFP plus 6 Gy irradiation; (4) Ad5-RbAp48 alone; andFig. 3. Overexpression of RbAp48 enhances radiosensitivity of cervical cancer cells. (A) We
lines (pcDNA3.1-RbAp48) and control cell lines (pcDNA3.1). β-Tubulin was a loading cont
formation (E) of RbAp48-overexpressing cell lines (pcDNA3.1-RbAp48) and control cell line
experiments. *, P b 0.05; **, P b 0.01; ***, P b 0.001 versus the pcDNA3.1 group.(5) Ad5-RbAp48 plus 6 Gy irradiation. To compare the sensitization
for radiation of RbAp48 and cisplatin, HeLa cell implanted mice were
randomly assigned to 5 groups (groups 6–10; 5 mice per group) for
treatment when tumor xenografts were established: (6) Ad5-EGFP
alone; (7) Ad5-EGFP plus 6 Gy irradiation; (8) Ad5-RbAp48 plus 6 Gy
irradiation; (9) Cisplatin plus 6 Gy irradiation; and (10) Ad5-RbAp48
and Cisplatin plus 6 Gy irradiation. Mice received 1 × 108 pfu virus or
PBS by intratumoral injection at days 0, 3, 6, 9 and 12, andwere exposed
to 0 or 6 Gy irradiation 24 h after each injection. For cisplatin treatment
mice, 5 mg/kg cisplatin in 100 μl PBS was administrated by intraperito-
neal injection 2 h before radiation at days 1, 4, 7, 10 and 13.
Tumor volume was estimated by use of calipers with the formula
V(mm3) = 0.5 × ab2, where a and b represent the long diameter andstern blot assay of RbAp48 protein level in RbAp48-overexpressing cervical cancer cell
rol. Assay for cell proliferation (B), cell counting (C), survival (D) and soft agar colony
s (pcDNA3.1) treated with doses of radiation. Data are mean ± SD from 3 independent
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times per week. At day 30, mice were euthanized and tumors were
excised and weighed.Statistical analysis
Data are expressed as mean ± SD or SEM. Differences between
means were assessed by two-way ANOVA or Student t test by the use
of GraphPad Prism v6.0 (GraphPad, San Diego, CA, USA). P b 0.05 was
considered statistically signiﬁcant.Results
RbAp48 is an irradiation-inducible protein in cervical cancer
Radiation treatment signiﬁcantly increased both the mRNA and
protein levels of RbAp48 in SiHa, Caski and HeLa cells (Fig. 1).
Thus, RbAp48 is an irradiation-inducible protein in cervical cancer
cells.Fig. 4. RbAp48modulates radiation-induced G2/M cell-cycle arrest and apoptosis in cervical can
siRNA knockout inhibited (B) radiation-induced G2/M phase arrest. Plasmid overexpressio
(D) radiation-induced apoptosis. Data are mean ± SD from 3 independent experiments. **, PGene silencing of RbAp48 expression attenuates cellular response to
radiation in cervical cancer cells
To detect whether RbAp48 is related to the radiation response in
cervical cancer, we suppressed RbAp48 gene expression in SiHa, Caski
and HeLa cells by siRNA targeting RbAp48 (Fig. 2A). siRNA knockdown
of RbAp48-2 inhibited RbAp48 expression. siRNA knockdown of
RbAp48 enhanced radiation-induced cell proliferation was seen by
both increased cell proliferation (Fig. 2B, P values are in Supplemental
Table 3A) and cell number (Fig. 2C, P values are in Supplemental Table
3B). Consistently, reduced RbAp48 expression increased colony forma-
tion of cervical cancer cells in response to radiation, as evidenced by
increased survival (Fig. 2D, P values are in Supplemental Table 3C)
and soft agar colony formation (Fig. 2E, P values are in Supplemental
Table 3D).
Overexpression of RbAp48 enhances radiosensitivity of cervical cancer
cell lines
To further clarify the role of RbAp48 in radiosensitivity of cervical
cancer, we generated stable cell lines overexpressing RbAp48 in SiHa,cer cells. Plasmid overexpression of RbAp48 in cervical cancer cell lines enhanced (A) and
n of RbAp48 in cervical cancer cell lines enhanced (C) and siRNA knockout inhibited
b 0.01; ***, P b 0.001 versus radiation treated pcDNA3.1 or si-control group, respectively.
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with radiation had a greater effect on inhibiting cell proliferation and
viability of cervical cancer cells than radiation alone, as seen by reduced
cell proliferation and cell number, survival and soft agar colony forma-
tion (Fig. 3B–E, P values are in Supplemental Table 4). Thus, alteration
of RbAp48 expression affected the survival and viability of cervical
cancer cells with radiation treatment.RbAp48 promotes radiosensitivity by inducing G2/M phase cell-cycle
arrest and apoptosis in cervical cancer cells
We next analyzed the role of RbAp48 in the cell cycle in response
to radiation. The G2/M phase arrest was more marked in RbAp48-
overexpressed SiHa, Caski and HeLa cells treated with radiation
thanwith the control treatment (P b 0.01, b0.001, b0.001, respectively;
Fig. 4A). Meanwhile, radiation-induced G2/M phase arrest was amelio-
rated more in RbAp48-silenced SiHa, Caski and HeLa cells than control-
silenced cervical cancer cells (P b 0.001, b0.001, b0.001, respectively;
Fig. 4B). As well, RbAp48-overexpression in SiHa, Caski and HeLa cells
signiﬁcantly enhanced cell apoptosis induced by radiation treatment
(P b 0.001, b0.001, b0.001, respectively; Fig. 4C). Consistently, siRNA
knockdown of RbAp48 with radiation inhibited the apoptotic rate as
comparedwith control treatment (P b 0.01, b0.001, b0.001, respectively;
Fig. 4D).Fig. 5. Altered expression of RbAp48 regulates mRNA levels of p53, Rb and caspase-8 with r
(B) and caspase-8 (C) in SiHa, Caski and HeLa cells with various treatments. Expression of p
valueswere then calibrated against the pcDNA3.1 stable transfected (pcDNA3.1) or control siRN
independent experiments. **P b 0.01; ***P b 0.001 versus radiation treated pcDNA3.1 or si-conRbAp48 regulates mRNA expression of p53, Rb and caspase-8 in cervical
cancer cells in response to radiation
To elucidate the molecular mechanism of RbAp48-mediated
radiosensitivity of cervical cancer cells, we assessed the mRNA levels
of p53, Rb and caspase-8 in cervical cancer cell lines with altered
expression of RbAp48with radiation treatment. RbAp48overexpression
markedly enhanced the radiation-inducedmRNA levels of p53 andRb in
cervical cancer cells, and RbAp48 silencing greatly inhibited the mRNA
levels as compared with the control treatment (Fig. 5A and B, P values
are in Supplemental Table 5A and 5B). The ﬁndings for caspase-8 were
similar to those for p53 and Rb (Fig. 5C, P values are in Supplemental
Table 5C). Thus, RbAp48-mediated radiosensitivity of cervical cancer
cells may be due in part to regulation of cell-cycle or apoptosis-related
molecules, including p53, Rb and caspase-8, in response to radiation.
Overexpression of RbAp48 enhances radiosensitivity of cervical cancer
cells and tumor growth in vivo
To evaluate the potential role of RbAp48 as a therapeutic target in
radiation therapy of cervical cancer, we constructed a RbAp48 expression
adenovirus, Ad5-RbAp48, for infecting cervical cancer cells. Ad5-RbAp48
markedly enhanced the expression of RbAp48 in cells (Supplemental
Fig. 1A) and promoted their radiosensitivity (Supplemental Fig. 1B and
1C; P values are in Supplemental Table 6). Consequently, we used aadiation of cervical cancer cells. Real-time RT-PCR assay of mRNA levels of p53 (A), Rb
53, Rb and caspase-8 in each sample was normalized to that of β-actin. The normalized
A transfected (si-control) values thatwere arbitrarily set to 1. Data aremean ± SD from3
trol group, respectively.
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diosensitivity in vivo. With radiation treatment, tumor size (Fig. 6A and B,
P values are in Supplemental Table 7) andweight (SiHa: P b 0.001, HeLa:
P b 0.001; Fig. 6C)were lowerwith Ad5-RbAp48 infection thanwith con-
trol infection (Ad5-EGFP), regardless of cell line. Adenovirus-mediated
RbAp48 delivery might be a potential adjuvant approach to radiation
therapy for cervical cancer.
We further compared the sensitization of Ad5-RbAp48 infection and
cisplatin for radiation therapy. As shown in Supplemental Fig. 2, although
Ad5-RbAp48 infection or cisplatin alone dramatically enhanced the
inhibitory effect of radiation treatment to HeLa cells implanted tumor
growth in nudemice, cisplatin-treated tumorwasmore sensitive to radi-
ation compared with Ad5-RbAp48-infected tumor (P b 0.01). Addition-
ally, Ad5-RbAp48 infection combined with cisplatin administration
showed a potential synergy in sensitization for radiation with decreased
tumorweight comparedwith radiation-treated Ad5-RbAp48 or cisplatin
group, respectively (P b 0.01, P b 0.05; Supplemental Fig. 2B).
Discussion
High-energy radiation is used in radiation therapy to shrink
tumors and kill cancer cells by inducing DNA damage [19]. Radiation
is effective for treating many cancers, but a few tumor cells become
resistant to radiation and survive to cause relapse and metastasis in
some patients. RbAp48 is one of the molecular markers of radiation
sensitivity in human breast carcinoma and melanoma cell lines [15].
In the present study, we found that expression of RbAp48 was greatly
increased in cervical cancer cell lines in response to radiation.
Subsequently, we investigated the role of RbAp48 in radiosensitivity
of cervical cancer cells. Reduced or enhanced expression of RbAp48 in
cervical cancer cell lines led to increased or decreased cell proliferation
and colony formation after irradiation, so RbAp48 is critical for the
radiosensitivity of cervical cancer cells. In addition, tumor size and
weight in nude mice exposed to radiation were smaller after injectingFig. 6. Ad5-RbAp48 infection enhanced radiosensitivity of cervical cancer cells in vivo. (A) T
virus infection and irradiation. Data are mean tumor volume ± SEM. *, P b 0.05; **, P b 0.01
and weights of tumors from groups of mice. Horizontal bars in C indicate mean tumor weigthem with SiHa and HeLa cells with Ad5-RbAp48 than Ad5-EGFP
infection, so overexpression of RbAp48 enhanced the radiosensitivity
of cervical cancer cells in vivo. Both in vitro and in vivo data indicate
that RbAp48may have potential as a radiosensitizer in radiation therapy
of cervical cancer, besides its inhibitory effect in malignant transforma-
tion of cervical cancer cells.
With exposure to radiation, cells initiate complex responses, including
arrested cell cycle progression in the G1 and G2 phases, apoptosis and
DNA repair [20]. G2/M arrest and apoptosis are common phenomena
after DNA-damaging treatment [21]. In general, cells aremost radiosensi-
tive in theM andG2 phases butmost radioresistant in the S phase. There-
fore, targeting the G2 checkpointmay be an important strategy for cancer
therapy [22]. Here, we demonstrated that overexpression of RbAp48
accelerated and knockdown of RbAp48 inhibited the G2/M phase arrest
stimulated by radiation in cervical cancer cells. RbAp48-induced G2/M
phase arrest in cervical cancer cells may enhance the radiosensitivity of
cervical cancer cells.
RbAp48 overexpression can induce apoptosis in exocrine gland cells
[23]. Our data indicated that overexpression of RbAp48 greatly increased
the apoptotic rate of cervical cancer cells in response to radiation,
whereas decreased expression of RbAp48 diminished the radiation-
induced apoptosis. Therefore, RbAp48 contributes to the radiosensitivity
of cervical cancer cells by inducing cell apoptosis.
The intranuclear mechanisms that signal apoptosis after DNA
damage overlapwith those that initiate cell cycle arrest and DNA repair
[24]. p53 plays an important role in the cellular response to radiation
[25–29] and mediates apoptosis or cell-cycle arrest in response to
DNA damage [30]. Rb plays essential roles in both the G1/S and G2/M
checkpoints in response to DNA damage, as well as in regulating proper
cell proliferation [31,32]. The expression of Rb was found critical
for radiation-induced apoptosis in prostate cancer cells [33]. Here we
report that RbAp48 overexpression combined with radiation enhanced
themRNA levels of p53 and Rb in cervical cancer cells as comparedwith
radiation alone. Caspase is one of the key components of the apoptoticumor growth curves for mice with SiHa or HeLa implantation with and without adeno-
; ***, P b 0.001 versus group with Ad5-EGFP infection plus radiation. (B, C) Photographs
ht ± SEM. ***P b 0.001 versus group with Ad5-EGFP infection plus radiation.
608 L. Zheng et al. / Gynecologic Oncology 130 (2013) 601–608pathway and plays central roles in apoptosis [34]. In addition, radiation
relies on caspase-8 activity to help mediate p53-independent cell death
[35]. In this study, we demonstrated that RbAp48 modulated the
expression of caspase-8 in cervical cancer cells in response to radiation,
so RbAp48 regulates radiation-induced apoptosis by regulating both
p53-dependent and -independent pathways.
Cisplatin-based concurrent chemoradiation has beenwidely accepted
as the standard of care for patients with locally advanced cervical cancer
[36]. In the present study, we demonstrated that sensitization for radia-
tion of Ad5-RbAp48 infection is slightly worse than that of cisplatin
treatment, and Ad5-RbAp48 infection and cisplatin exhibited potential
synergy. Adenoviral vectors have several advantages over other vector
systems, including relative safety, ease of virus production, and high
transduction efﬁciency in both replicating and non-replicating cells [37].
However, studies have shown that adenoviral vectors also have several
disadvantages, such as temporary protein expression and induction of
both cellular and humoral immune responses to vector-derived antigens
[38]. Once viral DNA eventually disappears, repeat administration of ade-
noviral vectors is needed in treatment strategies for chronic conditions,
but the immune responses may hamper the following repeat adenovirus
administration.
Gene therapy is also limited by the delivery efﬁcacy of viral vectors
into target cells and normal tissue cytotoxicity. Comparingwith system-
ic delivery of viral vectors, intratumoral injection is a routinemethod for
local viral gene delivery that may improve interstitial transport of viral
vectors in tumor tissues and reduce systemic toxicity [39]. Hepatotoxicity
and no symptoms of hepatitis have been reported in the case of
adenoviral load detected in the liver in some phase I clinical trials
[38]. Additionally, transgene products can be detected in the liver of
mice two days after adenoviral vectors administration by intratumoral
injection [39]. These reports suggest that predilection for hepatotoxicity
is a potential limitation of adenoviral vectors.
In conclusion, RbAp48, the radiation-inducible protein, contributes
to radiosensitivity of cervical cancer cells. Identifying RbAp48 as a
novel critical mediator in the radiosensitivity of cervical cancer and
elucidating the associated molecular events provide insights into the
processes regulating the cellular response to radiation therapy in cervical
cancer. Considering its potent ability in promoting radiosensitivity,
RbAp48 also has great potential as a therapeutic target for irradiation
treatment of cancer, including cervical carcinoma.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygyno.2013.06.002.
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